*#GOMOJO 1111‎ > ‎GLOBAL GOALS‎ > ‎

Pitch YOUR Org

Pitch YOUR Org


Pitch YOUR Org


We facilitate Non-Profit Organizations introducing their program to their target groups and help to ensure the needs are satisfied. We follow the money and and connect the people who need help to the organizations receiving the funds. 

GOMOJO knows there is plenty of cash flow going around the table and we are working towards ensuring that relevant Federal funded institutions and employees are appropriately incentive to prioritize R&D commercialization;

Optimizing the management, discover ability and awards of Federal Funds

Increasing the utilization of Federally-funded research facilities by entrepreneurs and innovators;


CAPACITY BUILDING FOR COMMUNITY-BASED ORGANIZATIONS

Services offered:


Develop, implement, and evaluate training and internship programs.


Develop and deliver topical slide presentations and facilitate public discussions in a variety of settings.


Develop HIV-related science, prevention, and treatment curriculum and material.


Conduct and disseminate research on HIV-related issues of significance for Black Americans and all others.


Increase the knowledge and capacity of staff on a variety of HIV-related subjects.


Work across departments to ensure proper delivery of support materials and information to partner organizations.


Develop and deliver presentations and facilitate public discussions in a variety of settings.

For more information, contact hello@gomojo.us or call or 702-427-1611 with a description of your needs.


Global Fund Support and Consultation Services for #AIDSFREE Generation

posted Mar 26, 2015, 11:32 PM by MOJO MICHELE   [ updated Apr 27, 2015, 10:43 PM ]

#AIDSFREE #GOMOJO
Road Map for Saving Lives Goal: Scale Up Combination Prevention and Treatment

Road Map for Smart Investments

Going Where the Virus Is: Targeting Evidence-Based Interventions for Populations at Greatest Risk

Road Map for Shared Responsibility

Goal: Creating an AIDS-Free Generation Requires a Global Effort

Road Map for Driving Results with Science  


“The United States will become a place where new HIV infections are rare and when they do occur, every person, regardless of age, gender, race/ethnicity, sexual orientation, gender identity or socio‐economic circumstance, will have unfettered access to high quality, life‐extending care, free from stigma and discrimination.”

The Strategy outlined three primary HIV health outcome goals:


1) reducing new HIV infections,

2) increasing access to care and optimizing health outcomes for people living with HIV, and

3) reducing HIV‐related health disparities


To accomplish these goals, the President declared that we must undertake a more coordinated national response to the

HIV epidemic.  And that’s what the key Federal agencies involved in the fight against AIDS set out to do – working with

state, tribal and local governments, businesses, faith communities, philanthropy, the scientific and medical communities, educational institutions, people living with HIV, and others.    

It was and remains an ambitious undertaking, but one that we must continue to prioritize. As noted later in this report, recent national and jurisdictional data indicate we are making gains against HIV. We are making progress and we cannot afford to stop now. In fact, our efforts to implement the Strategy must continue to accelerate, concentrating investments in populations most affected by HIV and with the greatest HIV‐related health disparities, including gay and bisexual men, blacks, and Latinos.


Now, we have the potential to go much further. The nation's HIV prevention efforts are guided by a single, ambitious strategy for combating the epidemic: the National HIV/AIDS Strategy (NHAS).2  Recent scientific breakthroughs have equipped us with an unprecedented number of effective tools to prevent infection.3-6 And in many of the communities hardest hit by HIV, there is growing leadership and momentum for change.


  • Focusing on science-driven HIV prevention efforts by supporting and expanding targeted use of evidence-based HIV prevention approaches;

  • Making smarter investments by intensifying HIV prevention in the communities where HIV is most heavily concentrated;

  • Increasing access to HIV screening and medical care, including through implementation of the Affordable Care Act;

  • Supporting a shared response to the domestic epidemic through the support of HIV prevention efforts across all levels of society, including Federal, state, and local governments, centers of learning, faith-based communities, and the private sector.


Continue to Support the National HIV/AIDS Strategy (NHAS) and Expand Investments in Prevention, Care, and Research.


The Budget expands access to HIV/AIDS prevention and treatment activities and supports the goals of the National HIV/AIDS Strategy to reduce HIV incidence; increase access to care and optimize health outcomes for people living with HIV; and reduce HIV-related health disparities.


By providing resources for Affordable Care Act implementation, the Budget will support increased health care coverage for thousands of people living with HIV/AIDS and expand access to HIV testing for millions of Americans.


The Budget makes smarter investments by prioritizing HIV/AIDS resources within high-burden communities and among high-risk groups, including gay men, black Americans and Latino Americans.


Compared to 2012, the Budget increases domestic discretionary Health and Human Services (HHS) HIV/AIDS funding by $73 million and Veterans Affairs (VA) HIV/AIDS funding by $155 million.


Overall, total U.S. Government-wide spending on HIV/AIDS increases from $27.8 billion in FY 2012 to $29.7 billion in the FY 2014 Budget.


Increase Funding for HIV/AIDS Prevention and Service Integration.


The Budget includes $833 million, an increase of $10 million for the Centers for Disease Control and Prevention (CDC) to continue implementing the goals of the National HIV/AIDS Strategy by preventing HIV/AIDS among high-risk communities using evidence-based interventions.


The Budget redirects $40 million from less effective activities to support a new $40 million Community High-Impact Prevention initiative to improve systems that link persons recently diagnosed with HIV to care.

Health Department Funding

CDC funding: $359 million annually, FY2012-FY2016 (assumes level funding)

A new approach to health department funding that better matches prevention dollars to the HIV burden in every state, territory, and heavily affected city, focusing on high-impact interventions.



Expanded Testing Initiative

CDC funding: $111 million total, FY2007-FY2010

Targeted funding for HIV testing in communities at risk. Between 2007 and 2010, provided 2.8 million tests; resulted in more than 18,000 new HIV diagnoses; and helped avert $1.2 billion in direct medical costs.


Enhanced Comprehensive HIV Prevention Planning (ECHPP)

CDC funding: $34.8 million anticipated total, FY2010-FY2012

Innovative demonstration projects implementing combination prevention in 12 cities with the highest AIDS burden. For example, the Houston ECHPP project brought together a diverse range of government agencies to create new links between prevention, care, substance abuse, and other services that can reduce new HIV infections.


Community-Based HIV Prevention for Young MSM and Transgender Persons of Color

CDC funding: $50 million total, FY2012-FY2016 (assumes level funding)

Support for local HIV prevention efforts to reach young MSM and transgender people of color with HIV testing and linkages to care, support, and prevention services, as well as targeted behavioral interventions and other effective approaches.


Estimated Return on U.S. Investment in HIV Prevention, 1991 – 2006

  • More than 350,00 infections averted

  • More than $125 billion in direct medical costs saved


Our national investment in HIV prevention has contributed to dramatic reductions in the annual number of new infections since the peak of the epidemic in the mid-1980s, and an overall stabilization of new infections in recent years.14 Given continued increases in the number of people living with HIV, this stabilization is in itself a sign of progress. Other important signs of progress include dramatic declines in mother-to-child HIV transmission and reductions in new infections among injection drug users and heterosexuals over time.

HIV prevention has also generated substantial economic benefits. For every HIV infection that is prevented, an estimated $360,000 is saved in the cost of providing lifetime HIV treatment, resulting in significant cost-savings for the health care syste

Proven HIV Prevention Interventions

1-1 of 1